Ivano Baragetti

846 total citations
31 papers, 504 citations indexed

About

Ivano Baragetti is a scholar working on Nephrology, Surgery and Epidemiology. According to data from OpenAlex, Ivano Baragetti has authored 31 papers receiving a total of 504 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Nephrology, 5 papers in Surgery and 5 papers in Epidemiology. Recurrent topics in Ivano Baragetti's work include Chronic Kidney Disease and Diabetes (6 papers), Dialysis and Renal Disease Management (6 papers) and Parathyroid Disorders and Treatments (4 papers). Ivano Baragetti is often cited by papers focused on Chronic Kidney Disease and Diabetes (6 papers), Dialysis and Renal Disease Management (6 papers) and Parathyroid Disorders and Treatments (4 papers). Ivano Baragetti collaborates with scholars based in Italy, United Kingdom and United States. Ivano Baragetti's co-authors include Alberico L. Catapano, G. Buccianti, Silvia Furiani, Giuseppe Danilo Norata, K. Garlaschelli, Liliana Grigore, Claudio Pozzi, Sara Raselli, Simone Vettoretti and Andrea Baragetti and has published in prestigious journals such as PLoS ONE, Kidney International and Clinical Chemistry.

In The Last Decade

Ivano Baragetti

29 papers receiving 491 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ivano Baragetti Italy 13 185 96 87 77 70 31 504
Alper Azak Türkiye 12 314 1.7× 161 1.7× 58 0.7× 44 0.6× 47 0.7× 32 465
Serpil Müge Değer Türkiye 17 259 1.4× 88 0.9× 48 0.6× 42 0.5× 32 0.5× 45 592
Lorenzo Gasperoni Italy 12 137 0.7× 101 1.1× 32 0.4× 135 1.8× 63 0.9× 30 518
Jean‐Marc Hurot France 13 320 1.7× 132 1.4× 27 0.3× 90 1.2× 53 0.8× 30 590
Ryutaro Shimazaki Japan 12 199 1.1× 69 0.7× 49 0.6× 35 0.5× 19 0.3× 20 466
K S Ang France 12 280 1.5× 38 0.4× 75 0.9× 47 0.6× 43 0.6× 23 588
Massimo Morosetti Italy 13 430 2.3× 94 1.0× 37 0.4× 44 0.6× 48 0.7× 57 702
Umut Selda Bayrakçı Türkiye 13 189 1.0× 81 0.8× 63 0.7× 20 0.3× 61 0.9× 59 510
Alper Kırkpantur Türkiye 16 247 1.3× 112 1.2× 42 0.5× 25 0.3× 27 0.4× 34 583
Frank P. Brouwers Netherlands 13 83 0.4× 80 0.8× 43 0.5× 104 1.4× 42 0.6× 20 866

Countries citing papers authored by Ivano Baragetti

Since Specialization
Citations

This map shows the geographic impact of Ivano Baragetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivano Baragetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivano Baragetti more than expected).

Fields of papers citing papers by Ivano Baragetti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivano Baragetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivano Baragetti. The network helps show where Ivano Baragetti may publish in the future.

Co-authorship network of co-authors of Ivano Baragetti

This figure shows the co-authorship network connecting the top 25 collaborators of Ivano Baragetti. A scholar is included among the top collaborators of Ivano Baragetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivano Baragetti. Ivano Baragetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baragetti, Ivano, Lucia Del Vecchio, Francesca Ferrario, et al.. (2024). The safety of corticosteroid therapy in IGA nephropathy: analysis of a real-life Italian cohort. Journal of Nephrology. 38(1). 225–234. 3 indexed citations
2.
Buzzi, Laura, et al.. (2024). Insights into the real-world practice of vascular access care pathways in Italy: data from a national survey. Journal of Nephrology. 38(2). 481–489.
3.
Rombolà, Giuseppe, et al.. (2021). SARS-CoV-2 and Hemodialysis: diffusion and mortality in patients and health care team. Reflections from the Lombardy experience. Journal of Nephrology. 34(2). 277–279. 1 indexed citations
4.
Alberici, Federico, Ivano Baragetti, Francesca Ferrario, et al.. (2020). MO040LONG-TERM FOLLOW-UP OF IGA NEPHROPATHY PATIENTS AT HIGH RISK OF PROGRESSION ACCORDING TO THE THERAPEUTIC APPROACH EMPLOYED: A MULTICENTER RETROSPECTIVE STUDY OF 947 PATIENTS. Nephrology Dialysis Transplantation. 35(Supplement_3). 1 indexed citations
5.
Vecchio, Lucia Del, et al.. (2019). New agents to reduce cholesterol levels: implications for nephrologists. Nephrology Dialysis Transplantation. 35(2). 213–218. 5 indexed citations
6.
Milia, Vincenzo La, Ivano Baragetti, Laura Buzzi, et al.. (2019). Sodium removal and plasma tonicity balance are not different in hemodialysis and hemodiafiltration using high-flux membranes. Journal of Nephrology. 32(3). 461–469. 10 indexed citations
7.
Ferrario, Francesca, et al.. (2016). [Assisted peritoneal dialysis].. PubMed. 31(6). 2 indexed citations
8.
Baragetti, Ivano, Giuseppe Danilo Norata, Andrea Baragetti, et al.. (2013). -374 T/A RAGE Polymorphism Is Associated with Chronic Kidney Disease Progression in Subjects Affected by Nephrocardiovascular Disease. PLoS ONE. 8(4). e60089–e60089. 9 indexed citations
9.
Ferrario, Francesca, et al.. (2011). [The ambiguous concept of predialysis: proposal for a model].. PubMed. 28(5). 541–50. 1 indexed citations
10.
Norata, Giuseppe Danilo, Ivano Baragetti, Sara Raselli, et al.. (2009). Plasma adiponectin levels in chronic kidney disease patients: Relation with molecular inflammatory profile and metabolic status. Nutrition Metabolism and Cardiovascular Diseases. 20(1). 56–63. 31 indexed citations
11.
Norata, Giuseppe Danilo, M. Ongari, K. Garlaschelli, et al.. (2007). Effect of the −420C/G variant of the resistin gene promoter on metabolic syndrome, obesity, myocardial infarction and kidney dysfunction. Journal of Internal Medicine. 262(1). 104–112. 52 indexed citations
12.
Baragetti, Ivano, Sara Raselli, Andrea Stucchi, et al.. (2007). Improvement of endothelial function in uraemic patients on peritoneal dialysis: a possible role for 5-MTHF administration. Nephrology Dialysis Transplantation. 22(11). 3292–3297. 12 indexed citations
13.
Filippo, Salvatore Di, Simeone Andrulli, S. Mangano, et al.. (2006). Reduction in urea distribution volume over time in clinically stable dialysis patients. Kidney International. 69(4). 754–759. 1 indexed citations
14.
Baragetti, Ivano, Silvia Furiani, Simone Vettoretti, et al.. (2006). Role of Vitamin E-Coated Membrane in Reducing Advanced Glycation End Products in Hemodialysis Patients: A Pilot Study. Blood Purification. 24(4). 369–376. 35 indexed citations
15.
Buccianti, G., et al.. (2004). Plasma homocysteine levels and cardiovascular mortality in patients with end-stage renal disease. Journal of Nephrology. 17(3). 405–410. 54 indexed citations
16.
Bamonti, Fabrizia, et al.. (2003). [Intravenous folinic acid and vitamin B12 supplementation and homocysteine concentration in hemodialysis patients].. PubMed. 19(3). 301–7. 2 indexed citations
17.
Scanziani, Renzo, et al.. (1999). Vaginal colonization with group B Streptococcus (Streptococcus agalactiae) and peritonitis in a woman on CAPD. Nephrology Dialysis Transplantation. 14(9). 2222–2224. 10 indexed citations
18.
Vezzoli, Giuseppe, Daniele Cusi, Laura Soldati, et al.. (1996). Different effects of PTH on erythrocyte calcium influx. 10. 149–152. 1 indexed citations
20.
Salvatore, Marco, et al.. (1993). Effect of a low-molecular-weight heparin, calcium nadroparine (CY216), on fibrinolysis in patients undergoing surgery. Current Therapeutic Research. 53(2). 180–187. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026